Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduce... (aara CEO andco-founder of Northern Antib...)

Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity

Date:7/1/2008

aara, CEO and co-founder of Northern Antibiotics Ltd.

"The need for well-tolerated antibiotics that are active against multidrug-resistant Gram-negative bacteria is urgent. Enteric bacteria are responsible for more than 80% of all the hospital infections caused by Gram-negative bacteria, and now they are rapidly becoming resistant to most antibiotics that are currently used to treat them. Plasmid-mediated carbapenemases, probably transferred from Klebsiella pneumoniae, have now been found in E. coli, the clinically most important species of Gram-negative enteric bacteria. Also plasmid-mediated methylases that cause resistance to all aminoglycosides have been encountered. Finally and quite alarmingly, a single genetic element conferring transferable resistance to carbapenems, aminoglycosides and fluoroquinolones has been reported in K. pneumoniae. One does not need to be very smart to guess what follows when these plasmids become more common and the resulting extremely multidrug-resistant strains start to spread."

About Northern Antibiotics Ltd.

Founded in 2003 and headquartered in Helsinki, Finland, Northern Antibiotics Ltd is engaged in the discovery and development of novel antibiotics against multidrug-resistant Gram-negative bacteria. For more information, visit http://www.northernantibiotics.com.

Contact:

Dr. Barry Mason

Business Development Consultant

Email: barry.mason@northernantibiotics.com

Phone: +44(0)1625-858396

Mobile: +44(0)7713-261356

SOURCE Northern Antibiotics Ltd
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2
Related medicine technology :

1. Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
2. ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics
3. For Most, Good Oral Care Does More Than Antibiotics to Prevent Dental-Related Heart Problems, Reports the Harvard Heart Letter
4. Nventa Develops Proprietary Vaccine Adjuvant
5. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
6. DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin
7. Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome
8. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
9. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
10. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
11. New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma

Post Your Comments:

(Date:8/19/2008).../- VION,PHARMACEUTICALS, IN...,entered into an agreement with the Dutch-Belgian ...he "HOVON") to conduct a clinical trial of,laromus...mission-induction,therapy in patients aged 18-65 w...a (AML) and high-risk myelodysplasia (MDS)., Alan...

(Date:8/18/2008)...for increased life expectancy for people with,Down...wire/ -- In the world of Down,syndrome, ,Mr. C, is...racked for the past 16 years, at seventy, ,Mr. C, ...a person with Down syndrome, currently in the,late...Further, ,Mr. C, does,not exhibit clinical symptom...

(Date:8/18/2008)...Newswire-FirstCall/ -- Micromet, Inc.,(Nasdaq: MI..., proprietary,antibodies for the treatment of canc...t a webcast and conference call this morning, Mond...:00 p.m. Central European,Time) to discuss the bli...SCIENCE on August 15, 2008., To access the webcas...

(Date:8/14/2008)...- Pharmasset, Inc.,(Nasdaq:...committed to,discovering, developing and commercia...rted unaudited financial results for the third fis...ed a net loss attributable to,common stockholders ... the,quarter ended June 30, 2008, as compared to a...

Breaking Medicine Technology:Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2 Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3 Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 2 Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 3 Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 2 Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 3 Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 4 Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2 Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3 Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4 Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5 Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6 Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7 Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8 Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9 Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen Deprivation Therapy 2287 1 Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen Deprivation Therapy 2287 2 Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen Deprivation Therapy 2287 3 Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen Deprivation Therapy 2287 4 Weizmann Institute scientists develop a new approach to treating autoimmune disease 20822 1 Weizmann Institute scientists develop a new approach to treating autoimmune disease 20822 2 Lung Cancer Alliance Hails Announcement of New Erbitux 28R 29 Data 2284 1 Lung Cancer Alliance Hails Announcement of New Erbitux 28R 29 Data 2284 2 Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 20816 1 Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 20816 2 Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 20816 3 Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 20816 4 Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 20816 5 Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 20816 6

[0] Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy [0] Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community [0] Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE [0] Pharmasset Reports Financial Results for Quarter Ended June 30, 2008

..., UK, June 11, 2007-ReGen is pleased to announce t...n on Colostrinin, its,nutraceutical product which ...healthy cognitive function, was presented today at...ne in Surfers,Paradise, Queensland, Australia by D... , The conference, which is being attended by key ...

...AKE CITY, UT, June 11, 2007 (MARKET WIRE via COMTE...MYGN) (<a target=,"_blank" href="http://www.myriad...esented a mathematical comparison of a,"Staggered ...l,design with a "Natural History Staggered Start" ...on Prevention Conference held,June 9 - 12, 2007, i...

Other Medicine Technology:Data Showing that ReGen's Colostrinin Supports Healthy Cognitive,Function Presented at the 2007 International Congress on Natural,Medicine in Australia 2 Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 2 Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 3 Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 4 Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 5

Data Showing that ReGen's Colostrinin Supports Healthy Cognitive,Function Presented at the 2007 International Congress on Natural,Medicine in Australia Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification

(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...

(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...

(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...

(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...

[0] Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use [0] Medicare Advantage Plans Struggle to Comply With New Federal Law [0] Longs Drug Stores Corporation Reports Second Quarter Results [0] WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History

...ST, the peer-reviewed journal of the American Coll...dietary intake of certain nutrients increases the ... especially in teens who smoke. Teenagers who for...e a harder time catching their breath. Furthermore...

...2007, issue of Neurology, the medical journal of t...ly Parkinsons disease report a higher than anticip...leepiness, and swelling. By identifying risk fact...isions, allow for early intervention and possibly ...

...mpaign to boost fruit and vegetable intake among y... Professor Janet Cade and colleagues of Leeds Un...nd Vegetable Scheme (SFVS), installed in 2004, on ... the north of England. A specially devised measure...

...therapy (HRT) should not be prescribed to older wo...ent chronic conditions such as heart disease . But...hort term treatment for younger women in early men...oms and improve quality of life. In 2002, the Wom...

Other Medicine News:Health News:Apple a Day Keeps Asthma Away 2 Health News:Apple a Day Keeps Asthma Away 3 Health News:Early Parkinsons Show Hallucination,sleepiness 2 Health News:Britains Free Fruit -And -Vegetable -Scheme Falls Flat 2 Health News:Study Confirms No HRT Benefit for Older Women 2 Health News:Study Confirms No HRT Benefit for Older Women 3

Apple a Day Keeps Asthma Away Early Parkinsons Show Hallucination,sleepiness Britains Free Fruit -And -Vegetable -Scheme Falls Flat Study Confirms No HRT Benefit for Older Women

...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...

Medicine Products:

Allergen, Food, Cherry Allergen, Food, Chicken Allergen, Food, Casein Allergen, Food, Blueberry

Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduce...(aara CEO andco-founder of Northern Antib...),Health